Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Bulbo-Spinal Atrophy, X-Linked × exemestane × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 53 Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms by Site 1 Multiple Endocrine Neoplasia Type 1 1 Locoregional Recurrence 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Granulosa cell tumor of the ovary 1 Endometrial Hyperplasia 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

darolutamide 2 abiraterone 2 pembrolizumab 1 enzalutamide 1 bicalutamide 1 apalutamide 1 abemaciclib 1 Prednisolone 1 Goserelin 1 Docetaxel 1 AZD5305 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡